Intervention

MRI Scan

ClinicalTrials.gov intervention label

Clinical trials10

Recruiting1

Common conditions12

Lead sponsors shown7

Clinical trials

10 shown

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).NCT06636526 · 2025-06-02

The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening.NCT03857477 · 2019-03-14

ACTIVE_NOT_RECRUITING

The Synapse ProjectNCT04871074 · 2018-11-18

pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic StressNCT03028675 · 2017-05-01

Advanced MRI for Uteroplacental Flow, Perfusion, Oxygenation & InflammationNCT02791568 · 2017-01-31

PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 MutationsNCT02983058 · 2016-11-01

Cardiac Implantable Electronic Device Magnetic Resonance Imaging RegistryNCT02459379 · 2016-06-01

MRI in Portal HypertensionNCT01756859 · 2013-01-01

Identifying Prostate Brachytherapy Seeds Using MRINCT01878058 · 2012-10-01

A Non-drug Methods Study in Participants With Alzheimer's DiseaseNCT01459016 · 2011-12-01

Common conditions

Prostate Cancer2 Alzheimer Disease1 Alzheimer's Disease1 Implantable Defibrillator Malfunction1 Multiple Sclerosis1 Obesity1 Pacemaker Malfunction1 Portal Hypertension1 Preeclampsia1 Pregnancy1 Prostate Cancer Patients Who Have Brachytherapy Seed Implant1 Schizophrenia1

Leading sponsors

Institute of Cancer Research, United Kingdom2 NYU Langone Health2 University of Wisconsin, Madison2 Eli Lilly and Company1 Jeffrey A. Lieberman, MD1 University Health Network, Toronto1 University of Nottingham1

Trial status mix

COMPLETED5

ACTIVE_NOT_RECRUITING1

RECRUITING1

TERMINATED1

UNKNOWN1

WITHDRAWN1

Phase mix

NA2

PHASE11

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.